Quantbot Technologies’s Kite Pharma, Inc. KITE Stock Holding History

Quantbot Technologies’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,803	Closed	-$234K	–	1549
2015 Q4	$234K	Buy	3,803 +2,903	+323%	+$204K	0.04%	421
2015 Q3	$50K	Buy	900 +800	+800%	+$50.3K	0.01%	913
2015 Q2	$6K	Sell	100 -700	-88%	-$39.9K	﹤0.01%	1024
2015 Q1	$46K	Sell	800 -399	-33%	-$26.7K	0.01%	797
2014 Q4	$69K	Buy	+1,199	New	+$50.5K	0.02%	760

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quantbot Technologies's KITE Position: Q1 2016 in Review

Quantbot Technologies sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 3,803 shares — an estimated $234K sold.

Quantbot Technologies first reported a position in KITE in Q4 2014 and held it in 5 quarters. The position peaked at $234K in Q4 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Quantbot Technologies reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
Quantbot Technologies sold 3,803 Kite Pharma, Inc. shares in Q1 2016, an estimated $234K.
Quantbot Technologies first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 5 quarters.
Quantbot Technologies's Kite Pharma, Inc. position peaked at $234K in Q4 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Quantbot Technologies's 13F filing for Q1 2016, filed 28 Apr 2016.